Impact of Specific KRAS Mutation in Exon 2 on Clinical Outcome of Chemotherapy- and Radiotherapy-Treated Colorectal Adenocarcinoma Patients
Crossref DOI link: https://doi.org/10.1007/s40291-014-0107-2
Published Online: 2014-05-24
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Roszkowski, Krzysztof
Zurawski, Bogdan
Jozwicki, Wojciech
Basta, Pawel
Lewandowska, Marzena Anna
License valid from 2014-05-24